Giving Where the Need is Greatest
Gilead Sciences funds innovative projects improving healthcare access and outcomes in HIV, liver disease, oncology, and health equity, prioritizing community impact and scientific advancement.
Funder: Gilead Sciences
Due Dates: Rolling (applications accepted year-round)
Funding Amounts: No specified minimum or maximum; budget requests should align with project needs.
Summary: Supports projects that break down barriers to healthcare, expand access, and strengthen health systems, especially in HIV, liver disease, oncology, and health equity.
Key Information: Strong alignment with Gilead’s core therapeutic areas and demonstrated community impact are prioritized.
Description
Gilead Sciences’ "Giving Where the Need is Greatest" program is designed to support organizations and initiatives that address significant barriers to healthcare access and improve health outcomes globally. The program focuses on supporting innovative, community-informed projects that enhance healthcare infrastructure, expand education and prevention, increase access to treatment, and reduce stigma and discrimination. Priority is given to projects related to HIV, liver diseases (including hepatitis B, C, D, and primary biliary cholangitis), oncology (hematology and solid tumors), and chronic inflammatory diseases. The program seeks to partner with organizations that can demonstrate a strong capability to deliver measurable impact for the communities most in need.
